EndoQuest Robotics vs Veeva Systems
Side-by-side comparison of AI visibility scores, market position, and capabilities
Flexible endoluminal surgical robot for GI procedures. $232M raised (Series D-2, Jul 2025); FDA-approved PARADIGM pivotal trial underway at Mayo Clinic, Cleveland Clinic, and Brigham and Women's.
About
EndoQuest Robotics is developing the Endoluminal Surgical (ELS) System, a flexible robotic platform designed for minimally invasive gastrointestinal surgery performed entirely through natural orifices — without external incisions. The system is engineered for therapeutic endoscopists and colorectal surgeons performing complex upper and lower GI procedures, including endoscopic submucosal dissection (ESD). EndoQuest closed a Series D-2 round in July 2025, co-led by Crescent Enterprises and Dr. Fred Moll (founder of Intuitive Surgical), bringing total funding to $232M. The FDA-authorized PARADIGM pivotal trial is actively enrolling 50 patients at five leading U.S. institutions — including Mayo Clinic, Cleveland Clinic, Brigham and Women''s Hospital, AdventHealth, and HCA Healthcare — with first ESD procedures completed in 2025. The FDA has cleared the final stage of the trial.
Veeva Systems (VEEV) reported $2.7B revenue in FY2025, up 14% YoY. #1 cloud platform for life sciences. ~8,000 employees. HQ: Pleasanton, CA. Market cap ~$40B.
About
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executive) and Matt Wallach, Veeva built its platform on Salesforce and later developed its own Vault cloud infrastructure. The company became a public benefit corporation (PBC) in 2021. Veeva reported revenues of $2.7B in fiscal year 2025 (ending January 2025), up 14% year-over-year, with a market capitalization of approximately $40B.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.